Replicel
Collapse
X
-
Comment
-
Comment
-
Comment
-
Replicel has been quiet over the last week. There has been no posting or updating on any of their social media websites since April 12th, which is out of character for them over the past 3-4 months. I don't know if "quiet rules" apply here. Quite rule requirements limit the types of communication that can take place up until public announcements, but I am not sure on the specifics or if they apply in Replicel's case.Comment
-
Hello, thanks for the comments! David Hall mentioned in the interview that "Phase I milestone in March is critical and we're confident that we're going to have hair growth. We're not going to go forward unless we have growth. If we achieve 20% percent growth, that would be a home run in terms of the comparative technologies out there.” RepliCel plans to release the results from the Phase I clinical trial in March, 2012.
With regards to safety, the primary purpose of the Phase I clinical trial titled “Study to Evaluate the Safety and Efficacy of Human Autologous Hair Follicle Cells in Women and Men with Androgenetic Alopecia” is to assess the safety of performing injections of human hair follicle cells. This will also be addressed when the Phase I trial results are released in March.
I hope this helps, and thank you for your interest!Comment
-
Replicel has been quiet over the last week. There has been no posting or updating on any of their social media websites since April 12th, which is out of character for them over the past 3-4 months. I don't know if "quiet rules" apply here. Quite rule requirements limit the types of communication that can take place up until public announcements, but I am not sure on the specifics or if they apply in Replicel's case.
Either way, everyone here should just stop speculating and read into every tiny detail.... won't do our hair any goodComment
-
Funding of Round II Trials
^ Quote:
Hello, thanks for the comments! David Hall mentioned in the interview that "Phase I milestone in March is critical and we're confident that we're going to have hair growth. We're not going to go forward unless we have growth. If we achieve 20% percent growth, that would be a home run in terms of the comparative technologies out there.” RepliCel plans to release the results from the Phase I clinical trial in March, 2012.
Total Raised Since February 2012:
Dollars
2/29/2012 $99,456
3/29/2012 $1,314,063
4/18/2012 $754,001
4/20/2012 $645,050
Total ...... $2,812,570
Total Needed for Round II: $5-$10 Million
Round IIb Test only: $3-$4 Million
% of Round II Funding Completed:
IIB Test only 80.36% (Using average of $3.5 Million range)
Low Figure 56.25%
High Figure 28.13%
So, by deduction:
1) Hall has stated that they are not going forward unless they have hair growth
2) Replicel has raised between 28% and 56% of the range indicated they would need to fund round II testing including operating costs
3) Therefore, Replicel must have shown good results in the initial phase
Assumptions:
1) Replicel already knows the results
2) The money being raised is not being used for a revised Phase I trialComment
-
Is it bad that I am more excited for this announcement, than I was when I was young waiting for Christmas? Let's hope its goodComment
-
Comment
Comment